TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
TipRanks Clinical-Trials-Auto-Generated Newsdesk
TipRanks Reporter
TipRanks’s Recent Articles
Novo Nordisk’s Semaglutide Study: A Boost for Diabetes and PAD Treatment?
Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Novo Nordisk recently completed a clinical study...
4h ago
NOVA
AstraZeneca’s Ondexxya Study: A Closer Look at Safety and Effectiveness
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
4h ago
AZN
Pfizer’s ABRYSVO Vaccine Study: A Potential Game-Changer for Infant Health
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Study Overview: Pfizer Inc. is conducting a...
4h ago
PFE
Karuna Therapeutics Advances Alzheimer’s Psychosis Treatment with KarXT Study
Karuna Therapeutics, Inc. (($KRTX)) announced an update on their ongoing clinical study. Study Overview: Karuna Therapeutics, Inc. is...
4h ago
KRTX
AstraZeneca’s NASH Study Completes: Market Implications of AZD4831
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
4h ago
AZN
Pfizer’s Inclacumab Study: A Promising Step for Sickle Cell Disease Treatment
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a clinical study...
4h ago
PFE
Corcept Therapeutics’ MOMENTUM Study: A Closer Look at Hypercortisolism in Resistant Hypertension
Corcept Therapeutics (($CORT)) announced an update on their ongoing clinical study. Corcept Therapeutics is conducting a study titled...
4h ago
CORT
AstraZeneca’s Latest Study on Inhaler Propellants: Key Insights for Investors
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
4h ago
AZN
Pfizer’s Gene Therapy Trial for Duchenne Muscular Dystrophy: A Market Game-Changer?
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 3...
4h ago
PFE
Eli Lilly’s Remternetug Study: A Potential Game-Changer in Drug Delivery
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and...
4h ago
LLY
Bayer’s Observational Study on Eylea in Preterm Infants: Market Implications
Bayer AG (($BAYRY)), Bayer Ag (UK) (($GB:0P6S)) announced an update on their ongoing clinical study. Study Overview: Bayer...
4h ago
Sanofi’s Promising Phase 2 Study on Atopic Dermatitis Treatment: Key Insights for Investors
Sanofi SA (($SNY)), Sanofi (($DE:SNW)), Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi SA, in...
4h ago
SNY
Pfizer’s Vizimpro Study: Key Insights for Investors
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is currently conducting a Korea...
5h ago
PFE
Bayer’s Finerenone Study in India: A Boost for CKD Treatment Market
Bayer AG (($BAYRY)), Bayer Ag (UK) (($GB:0P6S)) announced an update on their ongoing clinical study. Bayer AG has...
5h ago
Pfizer’s ATGAM Study: A Key Update for Investors
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Study Overview: Pfizer Inc. is conducting a...
5h ago
PFE
Pfizer’s New Phase 1 Trial: A Potential Game Changer in Cancer Treatment?
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 1...
5h ago
PFE
Edwards Lifesciences’ PASCAL System: A Promising Solution for Tricuspid Regurgitation
Edwards Lifesciences Corp. (($EW)) announced an update on their ongoing clinical study. The Edwards CLASP TR Early Feasibility...
5h ago
EW
AstraZeneca’s Real-World Study on Dapagliflozin: A Strategic Move in Heart Failure Treatment
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
5h ago
AZN
Covance’s Pediatric Study on Regadenoson: A Potential Game-Changer in Pediatric Cardiology
Covance (($CVD)) announced an update on their ongoing clinical study. The clinical study titled An Open-label, Single-dose, Safety...
5h ago
CVD
AstraZeneca’s SERENA-1 Study: A Promising Development in Breast Cancer Treatment
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
5h ago
AZN
Novo Nordisk’s Weekly Insulin Icodec Study: A Game Changer for Diabetes Management?
Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Novo Nordisk has recently completed a clinical...
5h ago
NOVA
Novo Nordisk’s IcoSema Study: A New Hope for Type 2 Diabetes Management
Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. In a recent clinical study update, Novo...
5h ago
NOVA
ImmunityBio’s Innovative Approach to Ovarian Cancer: A Phase 2 Study Update
Immunitybio Inc (($IBRX)) announced an update on their ongoing clinical study. Study Overview: ImmunityBio, Inc. is conducting a...
5h ago
IBRX
Novo Nordisk’s New Study on Wegovy: Real-world Insights Await
Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Novo Nordisk has announced a new observational...
5h ago
NOVA
Celltrion’s CT-P6 Study: A Potential Game-Changer in Biosimilars
Celltrion (($CONIF)) announced an update on their ongoing clinical study. Celltrion’s latest clinical study, titled A Randomized, Double-blind,...
5h ago
CONIF
Celgene’s New Study on Multiple Myeloma: A Potential Game-Changer?
Celgene Corporation (($CELG)) announced an update on their ongoing clinical study. Study Overview: Celgene Corporation is spearheading a...
5h ago
CELG
Sanofi’s Amlitelimab Study: Long-term Safety and Efficacy in Atopic Dermatitis
Sanofi SA (($SNY)), Sanofi (($SNYNF)), Sanofi (($DE:SNW)) announced an update on their ongoing clinical study. Sanofi is conducting...
5h ago
SNY
AstraZeneca Completes Key Study on Asthma and COPD Diagnostics
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
5h ago
AZN
Pfizer’s Latest Study on COVID-19 Vaccine Effectiveness: What Investors Need to Know
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a study titled...
5h ago
PFE
Regeneron’s Gene Therapy Study: A Long-Term Look at Safety and Efficacy
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals is launching a...
5h ago
REGN
Edwards Lifesciences’ Pivotal Trial: A Game Changer in Tricuspid Valve Repair?
Edwards Lifesciences Corp. (($EW)) announced an update on their ongoing clinical study. Edwards Lifesciences Corp. is conducting a...
5h ago
EW
Novo Nordisk’s Promising Diabetes Study: A Potential Game-Changer?
Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. In a recent clinical study update, Novo...
5h ago
NOVA
Pfizer’s Rimegepant Pregnancy Study: Key Insights for Investors
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a study titled...
5h ago
PFE
ImmunityBio’s Novel Approach to Combat Lymphopenia: A Market Game-Changer?
Immunitybio Inc (($IBRX)) announced an update on their ongoing clinical study. ImmunityBio Inc. is conducting a study titled...
5h ago
IBRX
Pfizer’s Latest Study on COVID-19 and Influenza: Key Insights for Investors
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. has launched a study titled...
5h ago
PFE
ImmunityBio’s Innovative Approach to Bladder Cancer Treatment: A Clinical Study Update
Immunitybio Inc (($IBRX)) announced an update on their ongoing clinical study. ImmunityBio Inc. is conducting a clinical trial...
5h ago
IBRX
Sanofi’s Phase 2 Study on SAR444656: A Potential Breakthrough for Hidradenitis Suppurativa
Sanofi SA (($SNY)), Sanofi (($SNYNF)), Sanofi (($DE:SNW)) announced an update on their ongoing clinical study. Sanofi is conducting...
5h ago
SNY
United Therapeutics’ Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis: Key Insights for Investors
United Therapeutics Corp. (($UTHR)) announced an update on their ongoing clinical study. United Therapeutics Corp. is currently conducting...
5h ago
UTHR
Medtronic’s Mid-Q Response Study: A New Chapter in Cardiac Care
Medtronic (($MDT)) announced an update on their ongoing clinical study. Medtronic’s Mid-Q Response Study, officially titled the same,...
5h ago
MDT
Stemline’s Promising Phase 3 Study on Elacestrant for Early Breast Cancer
Stemline (($STML)) announced an update on their ongoing clinical study. Stemline Therapeutics, Inc. is conducting a pivotal Phase...
5h ago
STML
Pfizer’s Somatrogon Study: A Closer Look at Safety in Pediatric Growth Hormone Deficiency
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a study titled...
5h ago
PFE
Pfizer’s Migraine Study: A Potential Game-Changer for Investors?
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 4...
5h ago
PFE
Pfizer’s New Pediatric Study on Abrocitinib: A Potential Game-Changer for Eczema Treatment
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is launching a Phase 3,...
5h ago
PFE
AstraZeneca’s New CKD Study: A Potential Game-Changer?
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
5h ago
AZN
Novo Nordisk’s Insulin Icodec Study in Youth: A Step Forward in Diabetes Care
Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. In a recent clinical study, Novo Nordisk...
5h ago
NOVA
Regeneron’s Cemiplimab Study: A New Hope for Early-Stage Skin Cancer?
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is conducting a Phase 3...
5h ago
REGN
Altimmune’s RESTORE TRIAL: A Promising Step in ALD Treatment
Altimmune (($ALT)) announced an update on their ongoing clinical study. Altimmune, Inc. is currently recruiting for the RESTORE...
5h ago
ALT
Pfizer’s Promising Migraine Study: A Potential Game-Changer for Adolescents
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is currently conducting a Phase...
5h ago
PFE
AstraZeneca’s Acalabrutinib Study: A Promising Update for B-cell Malignancies
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
5h ago
AZN
Pfizer’s Latest Study on HER2-positive Breast Cancer Treatment: What Investors Need to Know
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a study titled...
5h ago
PFE
SHOW MORE
You need to enable JavaScript to run this app.
